Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab [Phase 3]
Phase 3 study in Korean postmenopausal women with osteoporosis evaluating denosumab completed, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer [NA]
A study evaluating zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for prostate cancer has completed. The…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab [Phase 2]
Phase 2 clinical trial update describing a transiliac crest bone histology and histomorphometry study in postmenopausal women with low bone …
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer [NA]
This clinical trial update notes the completion of a study evaluating the impact of androgen suppression on bone loss in men with prostate c…
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women [Phase 2]
Phase 2 clinical trial update evaluating parathyroid hormone (PTH) for osteoporosis in postmenopausal women; the study has completed and res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-09-23FDA Approved: ZOLEDRONIC ACID — Original Application (Sagent Pharmaceuticals)
FDA approves a generic zoledronic acid injection from Sagent Pharmaceuticals under ANDA 202828, granting approval to market the product for …
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Pilot Study of Fosamax in Spinal Cord Injury [NA]
Pilot study evaluating alendronate (Fosamax) for osteoporosis in individuals with spinal cord injury; the trial was terminated and results w…
-
FDA approval · 2013-08-30FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
FDA has approved a supplemental application for teriparatide submitted by Prasco Laboratories, related to the NDA 021318 product.
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: The Effect of Protein Supplementation on Bone Health in Healthy Older Men and Women [Phase 1, Phase 2]
Phase 1/2 trial examining the effect of protein supplementation on bone health in healthy older adults with outcomes related to bone resorpt…
-
FDA approval · 2013-08-23FDA Approved: PROLIA — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for PROLIA (denosumab) submitted by Amgen, Inc., resulting in updated labeling for osteoporosis indi…
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Effect of Radius on Alpha Motor Neuron Excitability [NA]
A completed clinical trial update investigating the effect of Radius on alpha motor neuron excitability in osteoporosis.
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: A New Active Vitamin D, ED-71 for Osteoporosis [Phase 3]
Phase 3 trial of ED-71, an active vitamin D compound, for osteoporosis has completed.
-
FDA approval · 2013-08-02FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for teriparatide submitted by Prasco Laboratories, authorizing its marketing.
-
FDA label_change · 2013-08-02FDA Approved: BINOSTO — Supplemental Application (Radius Health, Inc.)
The FDA approved a supplemental application for BINOSTO (alendronate sodium) from Radius Health, updating the product labeling.
-
CLINICAL_TRIALS trial_result · 2013-08-01Clinical Trial Update: Nasally and sc Administered Teriparatide in Healthy Volunteers [Phase 1]
Phase 1 clinical trial evaluating nasal and subcutaneous administration of teriparatide in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2013-07-29Clinical Trial Update: Effect of Nutrition on Bone Metabolism as Assessed by 41Ca [NA]
This clinical trial update reports the completion of a study evaluating how nutrition influences bone metabolism as measured by 41Ca in indi…
-
FDA approval · 2013-07-15FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for alendronate sodium, manufactured by Amneal Pharmaceuticals of New York LLC. This action appr…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer [Phase 2]
Phase 2 trial evaluating zoledronic acid to prevent bone loss in men with prostate cancer undergoing androgen deprivation therapy has comple…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI) [Phase 4]
Phase 4 trial updates the effects of Parathyroid Hormone (PTH) and weight-bearing on bone health in people with spinal cord injury.
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Zinc and Bone Turnover Study in Adolescent Females [NA]
A completed clinical trial evaluating the effect of zinc on bone turnover in adolescent females. The study focused on bone health and growth…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Treatment of Calcium Deficiency in Young Women [Phase 2]
Phase 2 clinical trial update showing completion of a study evaluating a treatment for calcium deficiency in young women with osteoporosis.
-
CLINICAL_TRIALS research · 2013-06-26Clinical Trial Update: A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy
This completed cross-sectional study in female participants with epilepsy examines the effect of topiramate on bone and mineral metabolism, …
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate
This clinical trial update reports analyses of iliac crest biopsies from osteoporosis patients treated with risedronate.
-
FDA approval · 2013-06-03FDA Approved: ZOLEDRONIC ACID — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s original application for a generic zoledronic acid injectable product.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Longitudinal Study of Bone Mineral Density in Survivors of Solid Pediatric Cancers
A completed longitudinal clinical trial examining bone mineral density in survivors of solid pediatric cancers, focusing on osteoporosis.